Alan Celik (2025) “Impact of age and comorbidities on real-world outcomes in advanced breast cancer patients treated with palbociclib in first line: a nation-wide Danish retrospective study”, Acta Oncologica, 64, pp. 778–783. doi: 10.2340/1651-226X.2025.43226.